Travis Dalton bought $259K of Claritev (CTEV)
Executed May 18, disclosed May 19, 1 day later.
Over the 21 trading sessions from the disclosed entry session (May 19), the stock returned +85.8% (delay-adjusted); from the execution session (May 18), +137.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
Travis Dalton (Pres., CEO & Executive Chair) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales), most often in Claritev Corporation (CTEV). Across 3 priced purchase filings, the average 21-session return was +45.8% from execution and +31.5% from disclosure (delay-adjusted; derived). The largest single filing was $259K of CTEV (20,920 sh across 2 lots, as filed), executed May 18.
Healthcare · Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→4,500 sh × $38.81
Exec Aug 27
Filed Aug 31 · 8:50 AM ET CTEVPURCHASE Claritev Corporation $200K
15,380 sh × $13.00
Exec Feb 27
Filed Mar 2 · 4:38 PM ET CTEVPURCHASE Claritev Corporation $250K
5,290 sh × $47.23
Exec Nov 20 2025
Filed Nov 20 2025 · 5:57 PM ET CTEVPURCHASE Claritev Corporation $232K
3,982 sh × $58.30
Exec Aug 11 2025
Filed Aug 12 2025 · 4:19 PM ET CTEVPURCHASE Claritev Corporation $101K
5,252 sh × $19.20
Exec Mar 7 2025
Filed Mar 10 2025 · 5:30 PM ET